Erlotinib and vomiting 
Erlotinib and vomiting Patient Reports February 11, 2012
Erlotinib Side Effects Report #5803938-3
Erlotinib side effect was reported by a Physician from SPAIN on June 18, 2008. Female patient, 76 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, gastrointestinal toxicity, malignant neoplasm progression, nausea
, pancreatic carcinoma. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with GEMCITABINE, LOPERAMIDA, EPOETIN BETA, NEUPOGEN, BUPRENORFINE HYDROCHLORIDE, METAMIZOL MAGNESIUM, FENTANILO, ENOXAPARIN. Patient was hospitalized. Patient died on 02/09/2008.Erlotinib Side Effects Report #5230798-4
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Jan 17, 2007. Male patient, 59 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: depressed mood, fatigue, left ventricular failure, pleural effusion, vomiting. Erlotinib dosage: 100 MG QD, ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, OMEPRAZOLE, LOPERAMIDE, METOCLOPRAMIDE, FUROSEMIDE, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5391731-8
Erlotinib side effect was reported by a Physician from AUSTRALIA on July 09, 2007. Male patient, 56 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: calculus bladder, nephrolithiasis, renal colic, vomiting. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, ACETAMINOPHEN, DIPHENOXYLATE HYDROCHLORIDE, CAPECITABINE, RANITIDINE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5844647-4
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Aug 04, 2008. Female patient, 65 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haemoglobin increased, somnolence, unresponsive to stimuli, vomiting. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, CAPECITABINE, GEMCITABINE. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5862116-2
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Aug 11, 2008. Female patient, 65 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, platelet count decreased, somnolence, unresponsive to stimuli, vomiting. Erlotinib dosage: (100 MG,QD), ORAL. During the same period patient was treated with BEVACIZUMAB, CAPECITABINE, GEMCITABINE. Patient was hospitalized. Patient died on 07/15/2008.
Erlotinib Side Effects Report #5844647-4
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Aug 04, 2008. Female patient, 65 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haemoglobin increased, somnolence, unresponsive to stimuli, vomiting. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, CAPECITABINE, GEMCITABINE. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #6132638-8
Erlotinib side effect was reported by a Physician from UNITED STATES on Mar 09, 2009. Female patient, 60 years of age, weighting 125.2 lb, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: culture urine positive, dehydration, escherichia infection, mucosal inflammation, platelet count decreased, pneumonia klebsiella, vomiting. Erlotinib dosage: (100 MG,QD),ORAL. During the same period patient was treated with GEMCITABINE, XELODA. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5744848-X
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 02, 2008. Female patient was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, hypokalaemia, vomiting. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with EVEROLIMUS, AUGMENTIN, CELEXA, CENTRUM, ESTROGEN PATCH, LORTAB, NEXIUM, ZOFRAN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5916941-X
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 24, 2008. Female patient, 74 years of age, weighting 149.7 lb, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood lactate dehydrogenase increased, intra-abdominal haemorrhage, nausea
, platelet count increased, prothrombin time prolonged. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, COUMADIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5300467-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 26, 2007. Female patient, 57 years of age, weighting 160.0 lb, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, hypertension, nausea
. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, ARANESP, ATIVAN, ANZEMET. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5332790-8
Erlotinib side effect was reported by a Health Professional from FRANCE on May 08, 2007. Female patient, 56 years of age, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: constipation
, flatulence, small intestinal obstruction, subileus, vomiting. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with PAROXETINE, NOCTAMIDE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5775135-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 28, 2008. Male patient, 64 years of age, weighting 138.9 lb, was diagnosed with oesophageal carcinoma, multiple myeloma
and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: choking , dehydration, diarrhoea, epistaxis, nausea , oesophagitis, oral pain, weight decreased. Erlotinib dosage: (100 MG,QD) ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6063552-4
Erlotinib side effect was reported by a Physician from UNITED STATES on Jan 16, 2009. Male patient, 58 years of age, weighting 186.1 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, dysphagia, febrile neutropenia, penis disorder
, vomiting, white blood cell count decreased. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6083750-3
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 03, 2009. Male patient, 58 years of age, weighting 186.1 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, dehydration, diarrhoea, dysphagia, febrile neutropenia, penis disorder
, vomiting, white blood cell count decreased. Erlotinib dosage: 100 MG, DAYS 1-42, ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL, ROXICET, DOXYCYCLINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5783016-2
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2008. Male patient, weighting 138.9 lb, was diagnosed with oesophageal adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, disease progression, dysphagia, fatigue, nausea
, odynophagia, oral intake reduced, weight decreased. Erlotinib dosage: 150 MG, QD, PO. During the same period patient was treated with BEVACIZUMAB, PROGRAF, MYFORTIC, PREVACID, LIPITOR, PREDNISONE, METOPROLOL SUCCINATE, ASPIRIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5670074-9
Erlotinib side effect was reported by a Physician from GERMANY on Feb 26, 2008. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: constipation
, dehydration, fall , infection , malignant neoplasm progression, nausea . Erlotinib dosage: 150 MG (150 MG, QD), ORAL. During the same period patient was treated with OXYCODONE, MOVICOL, NEXIUM, NOVALGIN, INSULIN, METOCLOPRAMID, SPIRONOLACTONE. Patient was hospitalized. Patient died on 01/20/2007.Erlotinib Side Effects Report #5844734-0
Erlotinib side effect was reported by a Physician from POLAND on July 29, 2008. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bradykinesia, depressed level of consciousness, headache
, nausea , neurotoxicity, peripheral sensory neuropathy. Erlotinib dosage: 150 MG QD ORAL. During the same period patient was treated with METOCLOPRAMIDE, OMEPRAZOLE. Patient was hospitalized and became disabled. Patient recovered.Erlotinib Side Effects Report #6060234-X
Erlotinib side effect was reported by a Health Professional from BELGIUM on Jan 16, 2009. Female patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, dizziness
, nausea , oral fungal infection, renal failure acute, weight decreased. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with REPAGLINIDE, NEBIVOLOL, TIOTROPIUM, ENOXAPARIN, SERETIDE, ALLOPURINOL, SIMVASTATIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5007686-1
Erlotinib side effect was reported by a Physician from NETHERLANDS on Apr 19, 2006. Female patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: mallory-weiss syndrome, nausea
. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with ACENOCOUMAROL, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5009073-9
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 12, 2006. Male patient, 67 years of age, weighting 155.6 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: feeling abnormal, nephrolithiasis, vomiting. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with AVASTIN, CARBOPLATIN, TAXOL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5362706-X
Erlotinib side effect was reported by a Physician from SWEDEN on May 29, 2007. Male patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, lung neoplasm malignant, malignant neoplasm progression, malnutrition, nausea
, pain , performance status decreased. Erlotinib dosage: 150 MG, ORAL. During the same period patient was treated with OXYCONTIN, PREDNISOLONE, ACETAMINOPHEN, COZAAR, METOPROLOL TARTRATE, ENOXAPARIN, IMOVANE, OXYCODONE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6060255-7
Erlotinib side effect was reported by a Physician from POLAND on Jan 15, 2009. Female patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: fatigue, hypomagnesaemia, lung neoplasm malignant, malignant neoplasm progression, nausea
. Erlotinib dosage: unknown. During the same period patient was treated with AMARYL, MAGNESIUM, TRAMADOL, KETOPROFEN, OMEPRAZOLE, TORECAN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5990145-7
Erlotinib side effect was reported by a Physician from SWITZERLAND on Nov 25, 2008. Female patient, 56 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: headache
, hyperreflexia, myoclonic epilepsy, vomiting. Erlotinib dosage: 150 MG, ORAL. During the same period patient was treated with BEVACIZUMAB, ACETAMINOPHEN, FENISTIL, PANTOPRAZOLE, CITALOPRAM HYDROBROMIDE, MORPHINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5394874-8
Erlotinib side effect was reported by a Physician from FRANCE on July 05, 2007. Male patient, 49 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: gastroenteritis
, headache , vomiting. Erlotinib dosage: 150 MG (QD), ORAL; 150 MG (QD), ORAL. During the same period patient was treated with ZOLPIDEM TARTRATE, VITAMIN B, DI ANTALVIC. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5643861-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 12, 2008. Female patient, 47 years of age, weighting 183.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atelectasis, effusion, lung consolidation, nausea
, pneumonia . Erlotinib dosage: (150 MG, QD), ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5813696-4
Erlotinib side effect was reported by a Physician from UNITED STATES on July 16, 2008. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, metabolic acidosis, nausea
. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5875062-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Sept 08, 2008. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: clostridium difficile toxin test positive, dehydration, diarrhoea, haemoglobin decreased, nausea
, pyrexia. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5885500-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Sept 15, 2008. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: clostridium difficile toxin test positive, dehydration, diarrhoea, haemoglobin decreased, nausea
, pyrexia. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5910478-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Oct 06, 2008. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chills, clostridium difficile colitis, dehydration, diarrhoea, nausea
, pyrexia. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5944242-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 20, 2008. Male patient, 47 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: clostridium difficile colitis, dehydration, diarrhoea, haemoglobin decreased, nausea
, pseudomembranous colitis, pyrexia. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6073105-X
Erlotinib side effect was reported by a Health Professional from CANADA on Feb 02, 2009. Female patient, 45 years of age, weighting 135.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, hypocalcaemia, hypomagnesaemia, nausea
. Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with HUMULIN N, HUMULIN R, PERINDOPRIL ERBUMINE, CETIRIZINE, CRESTOR, ASPIRIN, PAROXETINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6088067-9
Erlotinib side effect was reported by a Health Professional from CANADA on Feb 06, 2009. Female patient, 45 years of age, weighting 135.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, hypocalcaemia, hypomagnesaemia, malaise, nausea
. Erlotinib dosage: (150 MG, QD) ,ORAL; (100 MG, QD) ,ORAL. During the same period patient was treated with HUMULIN M, HUMULIN R, PERINDOPRIL ERBUMINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6050202-6
Erlotinib side effect was reported by a Physician from CANADA on Jan 06, 2009. Female patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anxiety
, dehydration, hypophagia, nausea , pain . Erlotinib dosage: unknown. During the same period patient was treated with CISPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5450729-1
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 24, 2007. Female patient, 70 years of age, weighting 145.9 lb, was diagnosed with neoplasm and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: ascites, asthenia, cough, febrile neutropenia, haematocrit decreased, platelet count decreased, vomiting, white blood cell count decreased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, SENOKOT, ATIVAN, ACETAMINOPHEN, LEVAQUIN, MUCINEX, GUAIFENESIN, DARBEPOETIN ALFA. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6092896-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 20, 2009. Male patient, weighting 127.5 lb, was diagnosed with nasopharyngeal cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: constipation
, dehydration, nausea , pyrexia. Erlotinib dosage: 100 MG, QD. During the same period patient was treated with BEVACIZUMAB, CISPLATIN, ONDANSETRON, ACETAMINOFEN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5442832-7
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 28, 2007. Female patient, 79 years of age, weighting 101.0 lb, was diagnosed with metastatic neoplasm, neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, dysphagia, dyspnoea, vomiting. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5921249-2
Erlotinib side effect was reported by a Physician from CHILE on Sept 30, 2008. Female patient, 66 years of age, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, diplopia, hypertension, metastases to central nervous system, nausea
. Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with EUTIROX, ENALAPRIL MALEATE, ALPRAZOLAM, CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5755677-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 30, 2008. Female patient, 59 years of age, weighting 125.7 lb, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: electrocardiogram qt interval abnormal, hypovolaemia, metabolic acidosis, orthostatic hypotension, syncope vasovagal, vomiting. Erlotinib dosage: 150 MG ORAL ONCE DAILY. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #4608558-4
Erlotinib side effect was reported by a Pharmacist from on Mar 11, 2005. Female patient was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: nausea
, tremor. Erlotinib dosage: 150 MG DAILY ORAL. Patient recovered.Erlotinib Side Effects Report #6099808-9
Erlotinib side effect was reported by a Physician from JAPAN on Feb 13, 2009. Female patient, 75 years of age, weighting 143.3 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, arterial thrombosis limb, diarrhoea, disease progression, nausea
, rash . Erlotinib dosage: (150 MG, QD), ORAL; (150 MG, QD), ORAL. During the same period patient was treated with VITAMEDIN, METHYCOBAL, PRAVASTATIN, LOXONIN, SELBEX, NAUZELIN. Patient recovered.Erlotinib Side Effects Report #5792665-7
Erlotinib side effect was reported by a Physician from JAPAN on June 09, 2008. Female patient, 73 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dermatitis acneiform, hepatic function abnormal, paronychia, seborrhoeic dermatitis, vomiting. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with FAMOTIDINE, URSO, VITAMEDIN, CINAL, LENDORM, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5744845-4
Erlotinib side effect was reported by a Physician from UNITED STATES on May 01, 2008. Female patient, 55 years of age, weighting 153.0 lb, was diagnosed with head and neck cancer
and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood chloride decreased, cellulitis , hypomagnesaemia, nausea , pain . Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with CISPLATIN, SYMBAX, AMBIEN, ATIVAN, ROXICET, GLUCOVANCE, DILAUDID, FENTANYL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5800759-2
Erlotinib side effect was reported by a Physician from SPAIN on June 19, 2008. Female patient, 50 years of age, was diagnosed with head and neck cancer
and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dysphagia, food intolerance, mucosal inflammation, skin inflammation, vomiting. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with CISPLATIN, DICLOFENAC, FENTANILO, CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6099451-1
Erlotinib side effect was reported by a Health Professional from SPAIN on Feb 12, 2009. Female patient, 50 years of age, was diagnosed with head and neck cancer
and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dermatitis, dysphagia, food intolerance, mucosal inflammation, vomiting. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with CISPLATIN, DICLOFENAC, FENTANILO, CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5921832-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 16, 2008. Female patient, 13 years of age, weighting 366.8 lb, was diagnosed with glioma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, vomiting. Erlotinib dosage: 145MG/M2 QD PO. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6125199-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Mar 03, 2009. Male patient, 65 years of age, weighting 187.4 lb, was diagnosed with glioblastoma multiforme and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, hydrocephalus
, hypertension, nausea , neoplasm progression, treatment noncompliance. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, TEMODAR, LIPITOR, RINITIDINE, COLACE, LEVOTHYROXINE, ATIVAN, IMODIUM. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5916943-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 26, 2008. Female patient, weighting 120.8 lb, was diagnosed with glioblastoma multiforme and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cerebral disorder, convulsion, headache
, intracranial tumour haemorrhage, muscle twitching, nausea . Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with SORAFENIB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5822416-9
Erlotinib side effect was reported by a Physician from DENMARK on July 10, 2008. Male patient, 78 years of age, was diagnosed with gastrointestinal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood bilirubin increased, cholelithiasis, enterocutaneous fistula, gastrointestinal anastomotic leak, vomiting. Erlotinib dosage: 150 MG QD ORAL. During the same period patient was treated with BEVACIZUMAB, EMPERAL, NEXIUM. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6016661-X
Erlotinib side effect was reported by a Physician from HONG KONG on Dec 05, 2008. Male patient, 65 years of age, was diagnosed with colorectal cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal distension, cardiac arrest
, diarrhoea, dyspnoea, metabolic acidosis, vomiting. Erlotinib dosage: (25 MG) , ORAL. During the same period patient was treated with CAPECITABINE, OXALIPLATIN. Patient died on 12/02/2008.Erlotinib Side Effects Report #5963873-7
Erlotinib side effect was reported by a Physician from DENMARK on Nov 05, 2008. Female patient was diagnosed with colorectal cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: aphasia
, blood sodium decreased, headache , hypertension, ill-defined disorder, nausea , thyroid disorder. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5305173-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 30, 2007. Female patient, 62 years of age, weighting 259.0 lb, was diagnosed with colorectal cancer
and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, bacterial infection , blood culture positive, dehydration, febrile neutropenia, hypertension, nausea . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, ARANESP, LOMOTIL, ZOMETA, CIPRO. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5332791-X
Erlotinib side effect was reported by a Physician from CANADA on May 04, 2007. Male patient, 40 years of age, was diagnosed with colorectal cancer
and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: intestinal obstruction, pain , vomiting. Erlotinib dosage: unknown. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5231284-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Jan 19, 2007. Male patient, 64 years of age, weighting 162.0 lb, was diagnosed with colon cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, nausea
. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, PHENERGAN, PERCOCET, PAXIL, ARANESP. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5307862-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 06, 2007. Male patient, 64 years of age, weighting 162.0 lb, was diagnosed with colon cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood potassium decreased, nausea
. Erlotinib dosage: 150 MG QD, ORAL. During the same period patient was treated with TOPOTECAN, PHENERGAN, PERCOCET, PAXIL, ARANESP. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #4747976-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Aug 17, 2005. Male patient, weighting 147.7 lb, was diagnosed with colon cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: small intestinal obstruction, vomiting. Erlotinib dosage: 100MG QD ORAL. During the same period patient was treated with FLUOROURACIL, OXALIPLATIN, BEVACIZUMAB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5351034-4
Erlotinib side effect was reported by a Physician from UNITED STATES on May 23, 2007. Female patient, 56 years of age, was diagnosed with breast cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chills, gallbladder disorder, nausea
, neutropenia, platelet count decreased, white blood cell count decreased. Erlotinib dosage: 75 MG (QD); ORAL. During the same period patient was treated with VINFLUNINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5351040-X
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on May 21, 2007. Female patient, 56 years of age, weighting 150.4 lb, was diagnosed with breast cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: gallbladder disorder, nausea
, neutropenia, platelet count decreased, tremor. Erlotinib dosage: 75 MG (QD); ORAL. During the same period patient was treated with VINFLUNINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5862168-X
Erlotinib side effect was reported by a Physician from FRANCE on Aug 11, 2008. Male patient, 62 years of age, was diagnosed with adenocarcinoma pancreas and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: pneumonia aspiration, vomiting. Erlotinib dosage: (100 MG,QD),ORAL. During the same period patient was treated with GEMCITABINE, IMODIUM. Patient died.
Erlotinib Side Effects Report #4599678-1
Erlotinib side effect was reported by a Health Professional from on Mar 04, 2005. Female patient, 73 years of age, weighting 133.8 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: acute prerenal failure, blood pressure decreased, dehydration, diarrhoea, feeling abnormal, nausea
. Erlotinib dosage: 150 MG QD PO. During the same period patient was treated with ATENOLOL, COLCHICINE, FOLIC ACID, LIPITOR, ZESTORETIC, XANAX, OXYCODONE. Patient recovered.Erlotinib Side Effects Report #5284210-X
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 30, 2007. Female patient, 72 years of age, weighting 151.5 lb, was diagnosed with salivary gland cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, blood sodium decreased, eye infection
, fatigue, nausea , oral discomfort, staphylococcal infection . Erlotinib dosage: 75 MG PO QD. During the same period patient was treated with VINFLUNINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5088393-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on July 10, 2006. Male patient, 66 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, dehydration, diarrhoea, hypercalcaemia, nausea
, urinary tract infection , weight decreased. Erlotinib dosage: 150 MG (QD),ORAL. During the same period patient was treated with CETUXIMAB, ASPIRIN, NAPROXEN, LEVAQUIN. Patient was hospitalized. Patient recovered.